---
created: 2025-04-13
updated: 2025-04-13T10:51
id: xa{W5kXs3n
specialty: neuro
specialty_id: 208
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - source/ak-step1-v11::
  - theme/b&b::15-neuro::07-other::02-seizures
  - source/ak-step1-v11::
  - theme/firstaid::12-neuro-&-special-senses::06-pharm::01-epilepsy-therapy
  - source/ak-step1-v11::
  - theme/firstaid::12-neuro-&-special-senses::06-pharm::01-epilepsy-therapy::phenytoin
  - source/ak-step1-v11::
  - source/ome-banner::clinical::11-pediatrics::19-seizures
  - source/ak-step1-v11::
  - theme/physeo::09-pharm::14-neuro::03-epilepsy-carbamazepine,-phenytoin,-gabapentin,-tiagabine
  - source/ak-step1-v11::
  - theme/sketchypharm::06-neuro/psych::04-mood-stabilizers-&-antiepileptic-drugs::05-carbamazepine,-phenytoin,-gabapentin,-tiagabine,-vigabatrin
  - source/ak-step1-v11::^other::^highyield::2-relativelyhighyield
  - source/ak-step1-v11::^systems::neuro::pharmacology
  - source/ak-step2-v11::
  - theme/b&b::04-neuro::02-seziures::seizures-treatment"
type: flashcard
---

# Question
Adverse effects associated with phenytoin include diplopia and **nystagmus** (eye complications)

---

# Answer
